表紙
市場調查報告書
商品編碼
1069124

IPV疫苗全球市場:按疫苗品牌(POLIOVAC,SHANIPV,POLIORIX,IPOL/IMOVAX,POLYMILEX),按分銷渠道,按地區規模,份額,前景,機會分析2021-2028

IPV Vaccines Market, by Vaccine Brand (POLIOVAC, SHANIPV, POLIORIX, IPOL/IMOVAX, And POLYMILEX), by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球 IPV 疫苗市場預計將從 2021 年的 1.6 億美元增長到 2028 年的 2.4 億美元,在預測期內的複合年增長率為 8.5%。

各國政府推出了有益的疫苗接種計劃,為窮人提供疫苗接種,為全球滅活脊髓灰質炎疫苗(IPV)市場的增長創造了非常有利的環境。

本報告調查全球 IPV 疫苗市場,並提供有關市場前景、市場動態、市場分析、競爭條件等方面的全面信息。

目錄

第 1 章調查目標/先決條件

第二章市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
    • 市場細分:按疫苗品牌
    • 市場細分:按分銷渠道
    • 市場細分:按地區
  • 連貫的機會圖 (COM)

第三章市場動態、監管和趨勢分析

  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會
  • 影響分析
  • IPV 疫苗採用狀況:按國家/地區分類
  • 提供的 IPV 疫苗:由 UNICEF Gavi 提供
  • 開始和結束脊髓灰質炎疫苗接種的要求
  • 對受監管市場的貢獻(美國、5 個歐盟國家等)
  • 市場趨勢
  • 監管場景
  • 管道分析
  • 收購
  • PEST 分析
  • 公共和私人定價-IPV 疫苗
  • 流行病學

第 4 章全球 IPV 疫苗市場-冠狀病毒 (COVID-19) 大流行影響

  • COVID-19 對醫療市場的總體影響
  • COVID-19 流行病學

第 5 章全球 IPV 疫苗市場:按疫苗品牌(100 萬美元)(2021-2028 年)

  • 簡介
  • 脊髓灰質炎 (PFS/SD)
  • 沙尼普夫
  • 脊髓灰質炎
  • Ipol/Imovax
  • Polymilex

第 6 章全球 IPV 疫苗市場:按分銷渠道(100 萬美元)(2021-2028 年)

  • 簡介
  • 公共管理
  • 私人的

第 7 章全球 IPV 疫苗市場:區域性(100 萬美元)(2021-2028 年)

  • 簡介
  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章競爭態勢

  • 熱圖分析
  • 市場份額分析
    • GlaxoSmithKline Plc
    • 企業重點
    • 財務實績
    • Sanofi SA
    • 企業重點
    • 財務實績
    • Serum Institute of India Pvt. Ltd.
    • 企業重點
    • 財務實績
    • PT Bio Farma
    • 企業重點
    • 財務實績
    • AJ Vaccines
    • 企業重點
    • 財務實績

第9章 章節

目錄
Product Code: CMI4965

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at US$ 160 Mn in 2021 and is expected to increase to US$ 240 Mn by 2028, registering a CAGR of 8.5% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2019, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

  • This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

  • Global IPV Vaccines Market, by Vaccine Brand:
  • Poliovac (Pfs/Sd)
  • Shanipv
  • Poliorix
  • Ipol/Imovax
  • Polymilex
  • Global IPV Vaccines Market, by Distribution Channel:
  • Private
  • Public
  • Global IPV Vaccines Market, by Region:
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles:
    • GlaxoSmithKline Plc*
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • Sanofi S.A.
    • Serum Institute of India Pvt. Ltd.
    • PT Bio Farma
    • AJ Vaccines

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Vaccine Brand
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • IPV Vaccine Country wise Adoption Status
  • IPV Vaccines Supplied by UNICEF for Gavi
  • Polio Vaccination Entry and Exit Requirements
  • Contribution of Regulated Markets (U.S., EU5, and Others)
  • Market Trends
  • Regulatory Scenario
  • Pipeline Analysis
  • Acquisitions
  • PEST Analysis
  • Public and Private Pricing - IPV Vaccine
  • Epidemiology

4. Global IPV Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact of COVID-19 on Healthcare market
  • COVID-19 Epidemiology

5. Global IPV Vaccines Market, By Vaccine Brand, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Poliovac (PFS/SD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Shanipv
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Poliorix
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Ipol/Imovax
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Polymilex
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global IPV Vaccines Market, By Distribution Channel, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global IPV Vaccines Market, By Region, 2021 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • North America
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Vaccine Brand, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2028, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • GlaxoSmithKline Plc
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • Sanofi S.A.
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • Serum Institute of India Pvt. Ltd.
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • PT Bio Farma
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies
    • AJ Vaccines
    • Company highlights
    • Product Portfolio
    • Key Highlights
    • Financial performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact